Home > Healthcare > Medical Devices > Therapeutic Devices > End Stage Renal Disease Market
End Stage Renal Disease Market Share
- Report ID: GMI6256
- Published Date: Jul 2023
- Report Format: PDF
End Stage Renal Disease Market Share
Some of the major players operating in the end stage renal disease market are
- AngioDynamics, Inc.
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Baxter International, Inc.
- Becton Dickinson and Company
- Cantel Medical
- DaVita Inc.
- Fresenius Medical Care AG & Co. KGaA
- JMS Co. Ltd.
- Medtronic Plc
- Nikkiso Co., Ltd.
- Nipro Corporation
- Teleflex Incorporated
- Toray Industries Inc.
- U.S. Renal Care, Inc.
These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers.
Frequently Asked Questions (FAQ) :
Global market for end stage renal disease was around USD 114 billion in 2022 and will reach over USD 183.9 billion by the end of 2032.
The dialysis segment was over 83% in 2022 owing to rising number of people suffering from end stage renal disease.
North America market size was USD 51.1 billion in 2022 due to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from end stage renal diseases, surging elderly population, among others.
AngioDynamics, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Becton Dickinson and Company, Cantel Medical, DaVita Inc., Fresenius Medical Care AG & Co. KGaA, JMS Co. Ltd., Medtronic Plc, Nikkiso Co., Ltd., Nipro Corporation, Teleflex Incorporated, Toray Industries Inc., U.S. Renal Care, Inc. among others.
End Stage Renal Disease Market Scope
×
Get a free sample of
End Stage Renal Disease Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below